IFM Therapeutics lands $55.5 mln

Boston-based IFM Therapeutics, a biopharmaceutical company, has secured $55.5 million in financing.

Boston-based IFM Therapeutics, a biopharmaceutical company, has secured $55.5 million in financing. Omega Funds led the round with participation from existing investors Atlas Venture and Abingworth.

Source: Press Release